Tema ETFs’s Arcus Biosciences RCUS Stock Holding History

Tema ETFs’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.29M	Buy	88,847 +5,707	+7%	+$161K	0.09%	174
2026 Q2	$2.56M	Buy	83,140 +7,927	+11%	+$196K	0.08%	158
2026 Q1	$1.62M	Buy	75,213 +39,088	+108%	+$844K	0.11%	171
2025 Q4	$861K	Buy	36,125 +5,832	+19%	+$119K	0.07%	263
2025 Q3	$412K	Sell	30,293 -29,369	-49%	-$305K	0.03%	410
2025 Q2	$486K	Buy	59,662 +44,411	+291%	+$379K	0.13%	139
2025 Q1	$120K	Sell	15,251 -6,982	-31%	-$80.9K	0.04%	145
2024 Q4	$331K	Buy	+22,233	New	+$363K	0.14%	124

Other funds holding RCUS

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

AWM

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Tema ETFs's RCUS Position: Q3 2026 in Review

Tema ETFs increased its Arcus Biosciences (RCUS) stake by 6.9% in Q3 2026, buying an estimated $161K and bringing the position to 88,847 shares worth $2.29M. The position accounts for 0.09% of the portfolio, ranked #174.

Tema ETFs first reported a position in RCUS in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.56M in Q2 2026. 16 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

Tema ETFs held 88,847 shares of Arcus Biosciences worth $2.29M as of Q3 2026.
Tema ETFs bought 5,707 Arcus Biosciences shares in Q3 2026, an estimated $161K.
Arcus Biosciences made up 0.09% of Tema ETFs's portfolio in Q3 2026, its #174 holding.
Tema ETFs first reported a position in Arcus Biosciences in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Arcus Biosciences position peaked at $2.56M in Q2 2026.
16 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.